CEL-SCI Corp (STU:LSR) Stock News, Headlines & Updates
CEL-SCI Corp Stock News from GuruFocus
- 1
Jun 18, 2025
FDA's Approval of Keytruda for PD-L1 Positive Head and Neck Cancer Patients Signals a Clear Pathway for CEL-SCI's Multikine to Address a Major Unmet Need in PD-L1 Negative Cancer Patients | CVM Stock
GuruFocus News • 8:19am
May 23, 2025
CEL-SCI Announces Closing of Public Offering | CVM Stock News
GuruFocus News • 3:17pm
May 22, 2025
CEL-SCI (CVM) Prices Public Offering Amid Stock Slump
GuruFocus News • 4:55am
CVM Stock Offering Priced Below Previous Closing Value | CVM Stock News
GuruFocus News • 8:00pm
CEL-SCI Announces Pricing of Public Offering | CVM Stock News
GuruFocus News • 7:30pm
May 21, 2025
CEL-SCI Corporation (CVM) Plans Public Offering for R&D and Corporate Needs | CVM Stock News
GuruFocus News • 3:31pm
CEL-SCI Announces Proposed Public Offering | CVM Stock News
GuruFocus News • 3:19pm
CEL-SCI's Multikine Investigational Cancer Medicine Potentially Available for Commercialization by Summer 2025 in Saudi Arabia | CVM Stock News
GuruFocus News • 7:19am
CEL-SCI (CVM) Prepares to Submit Breakthrough Medicine Application in Saudi Arabia | CVM Stock News
GuruFocus News • 7:17am
May 19, 2025
CEL-SCI (CVM) Approves 1-for-30 Stock Consolidation | CVM Stock News
GuruFocus News • 2:15pm
CEL-SCI Announces Combination of Common Stock | CVM Stock News
GuruFocus News • 2:00pm
May 15, 2025
CEL-SCI Reports Fiscal Second Quarter 2025 Financial Results | CVM Stock News
GuruFocus News • 8:23am
Apr 23, 2025
- 1
Show
Entries
Headlines
Total 0- 1
No recent news